Uterine fibroids are noncancerous growths of the uterus. Sometimes, their removal requires major surgery, such as a hysterectomy. Gynesonics has developed a breakthrough alternative. Their Sonata System, using targeted radio frequency, is an incisionless procedure that doesn't require general anesthesia. It's a much safer and less invasive option, but it will remain unavailable to most women until insurance carriers cover the procedure. And that's where Lexi Faragon '21 enters the picture.
Faragon is working on a team that pitches the virtues of the Sonata System to insurers, by dispelling the "experimental" notion and describing the benefits.
"We are committed to providing women with a safe and effective incision-free alternative to the invasive surgical techniques of hysterectomy or myomectomy for their symptomatic uterine fibroids."
Faragon intends to pursue a career in pharmaceutical or medical sales. She landed the opportunity with Gynesonics when Kelly Petrucci, a Siena graduate and the global VP of strategy and market access for Gynesonics, decided to bring an intern on board, and only contacted her alma mater.
Faragon's first project involves contacting insurance companies... every success is a win for the company and a win for women.
"I am so grateful to have the opportunity, through this internship, to familiarize myself with the field I hope to enter into after graduation. Not only does this internship fall in line with my career goals, it also gives me the chance to work with a company that is producing a product to help better women's’ lives. Gynesonics offers a superior solution to a problem that many women face, while avoiding the chance of hindering other aspects of their lives. Being a part of something that may help better someone else not only goes along with my own values but also the values that Siena aims to instill in each of its students."
Lexi Faragon '21
